Literature DB >> 10919539

Hypophosphatemia in the emergency department therapeutics.

D W Miller1, C M Slovis.   

Abstract

Although hypophosphatemia is relatively uncommon, it may be seen in anywhere from 20% to 80% of patients who present to the ED with alcoholic emergencies, diabetic ketoacidosis (DKA), and sepsis. Severe hypophosphatemia, as defined by a serum level below 1.0 mg/dL, may cause acute respiratory failure, myocardial depression, or seizures. Because hypophosphatemia is not as often treated by ED physicians, becoming familiar with a single intravenous phosphate solution and specific guidelines for phosphate repletion are essential. One mL of the most commonly available phosphate solution (K2PO4) contains 4.4 meq of potassium and 3 mmol (93 mgs) of phosphate. Administering K2PO4 at a rate of 1 mL per hour is almost always a very safe and appropriate treatment for hypophosphatemia. This article provides guidelines for phosphate therapy in hypophosphatemic ED patients including those in DKA, those presenting with alcohol-related complaints including alcoholic ketoacidosis and patients with acute exacerbation of asthma and chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  2000        PMID: 10919539     DOI: 10.1053/ajem.2000.7347

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  9 in total

Review 1.  Severe hypophosphatemia associated with gallstone pancreatitis: a case report and review of the literature.

Authors:  David A Steckman; Jenifer L Marks; Mike K Liang
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

Review 2.  Alcoholic ketoacidosis.

Authors:  L C McGuire; A M Cruickshank; P T Munro
Journal:  Emerg Med J       Date:  2006-06       Impact factor: 2.740

3.  Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.

Authors:  Otmane Nafidi; Real W Lapointe; Raymond Lepage; Rajiv Kumar; Pierre D'Amour
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

4.  Approach to the hypophosphatemic patient.

Authors:  Erik A Imel; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2012-03       Impact factor: 5.958

Review 5.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

6.  On the effect of the injection of potassium phosphate in vivo inducing the precipitation of serum calcium with inorganic phosphate.

Authors:  Alcimar B Soares; José G Ticianeli; Letícia B M Soares; George Amaro
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-12-15

7.  Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury.

Authors:  Yi Yang; Ping Zhang; Yu Cui; Xia Lang; Jing Yuan; Hua Jiang; Wen Lei; Rong Lv; Yi Zhu; En Lai; Jiang Chen
Journal:  Crit Care       Date:  2013-09-19       Impact factor: 9.097

8.  Structure-function aspects of PstS in multi-drug-resistant Pseudomonas aeruginosa.

Authors:  Olga Zaborina; Christopher Holbrook; Yimei Chen; Jason Long; Alexander Zaborin; Irina Morozova; Hoylan Fernandez; Yingmin Wang; Jerrold R Turner; John C Alverdy
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

9.  The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury.

Authors:  Soo Young Kim; Ye Na Kim; Ho Sik Shin; Yeonsoon Jung; Hark Rim
Journal:  Kidney Res Clin Pract       Date:  2017-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.